Day One Biopharmaceuticals Inc (DAWN)
Stock-Based Compensation
$11.07M
Quarterly · Period ending: · USD
DAWN Stock-Based Compensation
Latest reported$11.07Mperiod ending
Latest reported$11.07Mperiod ending
DAWN Quarterly Stock-Based Comp ($59.00K → $11.07M)
Quarterly stock-based compensation
High-resolution chart · PNG
DAWN stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 11,068,000 | |
| 9,561,000 | |
| 10,898,000 | |
| 12,861,000 | |
| 11,035,000 | |
| 11,554,000 | |
| 13,030,000 | |
| 12,644,000 | |
| 10,811,000 | |
| 9,606,000 | |
| 9,477,000 | |
| 9,447,000 | |
| 6,833,000 | |
| 8,576,000 | |
| 5,631,000 | |
| 6,202,000 | |
| 5,097,000 | |
| 5,149,000 | |
| 2,537,000 | |
| 538,000 | |
| 350,000 | |
| 60,000 | |
| 57,000 | |
| 59,000 |